Clinical Trial Detail

NCT ID NCT02608125
Title A Dose Escalation and Dose Expansion Study of PRN1371 in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Principia Biopharma, Inc.
Indications

Advanced Solid Tumor

Therapies

PRN1371

Age Groups: senior adult

Additional content available in CKB BOOST